A promising candidate for a universal influenza vaccine
- PMID: 37517421
- DOI: 10.1016/S1473-3099(23)00366-3
A promising candidate for a universal influenza vaccine
Conflict of interest statement
We declare no competing interests.
Comment on
-
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial.Lancet Infect Dis. 2023 Dec;23(12):1360-1369. doi: 10.1016/S1473-3099(23)00351-1. Epub 2023 Jul 27. Lancet Infect Dis. 2023. PMID: 37517422 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
